Stanford University
EA Policies for Single Patient

We currently do not accept requests for expanded access use of our investigational products. Supporting single patient expanded access would negatively impact our resources and ability to complete the active clinical investigations.

We encourage anyone interested in receiving investigational products manufactured for Stanford Center for Cell Therapy investigator-initiated trials to contact the Principal Investigator through ClinicalTrials.gov listing to see if they are eligible to enroll on an open study.

Prostate Cancer

The purpose of this research study is to see if patients' tumor can be identified by18F-DCFPyL PET/MRI scan. The radioactive study agent, 18FDCFPyL, combined with PET/MRIscan may be able to identify smaller tumors than the standard of care contrast-enhancedCT or MRI scan.